Sort
51,593 grants matching “hepatitis”
Molecular Biology of Picornavirus Replication
$1,023,569Elvera Ehrenfeld · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Clinical Trials Units for NIAID Networks (UM1)
$1,022,484Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2015 · AI
Role of B Lymphocytes In HIV Infection And Pathogenesis
$1,022,245Susan Moir · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
THE SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP
$1,021,880University Of Texas Medical Br Galveston · U19 · FY2003 · AI
General Clinical Research Center
$1,021,752Richard D Krugman · University Of Colorado Denver · M01 · FY2008 · RR
Inhibition of hepatitis C by RNA-based therapeutics
$1,021,558Brian H. Johnston · Somagenics, Inc. · R44 · FY2007 · AI
Clinical Research on Nonalcoholic Fatty Liver Disease
$1,021,433Joel Edward Lavine · Columbia University Health Sciences · U01 · FY2011 · DK
RECOMBINANT AAV FOR CORRECTION OF GENETIC ABNORMALITIES
$1,021,143University Of Florida · P01 · FY2003 · DK
High Tc susceptometer for magnetic measure of body iron
$1,020,821Columbia University Health Sciences · R01 · FY2002 · DK
The PIP2-virus interface and PI 4-kinase: novel biology and validation targets
$1,020,814Jeffrey S Glenn · Stanford University · R01 · FY2013 · AI
Adaptable tissue-specific endothelial cells for organ regeneration
$1,020,606Shahin Rafii · Weill Medical Coll Of Cornell Univ · R35 · FY2021 · HL
Point-of-care diagnostic test for T. cruzi (Chagas) infection
$1,020,000Andrew E. Levin · Kephera Diagnostics, Llc · R44 · FY2023 · AI
Early detection of HCC using noninvasive activity-based nanosensors
$1,019,215Wendy Winckler · Glympse Bio, Inc. · R44 · FY2020 · CA
UCSF HIV Clinical Trials Unit
$1,018,836Diane V Havlir · University Of California, San Francisco · U01 · FY2009 · AI
Data Generation Core
$1,018,640Marc R. Birtwistle · Icahn School Of Medicine At Mount Sinai · U54 · FY2014 · HG
Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
$1,018,572Norah A. Terrault · University Of California, San Francisco · U01 · FY2017 · DK
VANDERBILT ADULT AIDS CLINICAL TRIALS UNIT
$1,018,550Vanderbilt University · U01 · FY2000 · AI
In vivo proton MRS studies:cerebral injury in HIV infection
$1,018,432Bradford A Navia · Tufts University Boston · R01 · FY2006 · NS
Investigation of management and disease manifestations of viral hepatitis
$1,018,322Theo Heller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Administrative Core
$1,018,230Craig J McClain · University Of Louisville · P20 · FY2025 · GM
Adaptable tissue-specific endothelial cells for organ regeneration
$1,017,773Shahin Rafii · Weill Medical Coll Of Cornell Univ · R35 · FY2025 · HL
Adaptable tissue-specific endothelial cells for organ regeneration
$1,017,773Shahin Rafii · Weill Medical Coll Of Cornell Univ · R35 · FY2022 · HL
Adaptable tissue-specific endothelial cells for organ regeneration
$1,017,773Shahin Rafii · Weill Medical Coll Of Cornell Univ · R35 · FY2023 · HL
Multidisciplinary Studies of Lymphoma
$1,017,034Patricia Hartge · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence
$1,016,716John M Littleton · Naprogenix, Inc · U44 · FY2021 · AA